Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
102,423,092
-
Shares change
-
-2,759,358
-
Total reported value, excl. options
-
$308,322,526
-
Value change
-
-$29,982,037
-
Put/Call ratio
-
127%
-
Number of buys
-
38
-
Number of sells
-
-49
-
Price
-
$3.01
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2019
128 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2019.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102,423,092 shares
of 363,214,619 outstanding shares and own 28% of the company stock.
Largest 10 shareholders include Artal Group S.A. (60,240,864 shares), FMR LLC (13,084,894 shares), Ulys, L.L.C. (4,321,214 shares), BlackRock Inc. (4,143,943 shares), VANGUARD GROUP INC (3,061,989 shares), BOXER CAPITAL, LLC (2,500,000 shares), NEA Management Company, LLC (2,382,286 shares), MILLENNIUM MANAGEMENT LLC (1,220,629 shares), UBS ASSET MANAGEMENT AMERICAS INC (1,119,200 shares), and STATE STREET CORP (952,606 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.